Literature DB >> 16647958

Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.

Song-Qing Fan1, Jian Ma, Jie Zhou, Wei Xiong, Bing-Yi Xiao, Wen-Ling Zhang, Chen Tan, Xiao-Ling Li, Shou-Rong Shen, Ming Zhou, Qiu-Hong Zhang, Yang-Jue Ou, Hou-De Zhuo, Songquing Fan, Yan-Hong Zhou, Gui-Yuan Li.   

Abstract

Studies have revealed that Epstein-Barr virus (EBV) infection, genetic aberration, and environmental factors are of importance in the development of nasopharyngeal carcinoma (NPC), although the definite mechanism remains to be fully elucidated. The aim of our study is to investigate using tissue microarray analysis whether differential expression of EBV-encoded small RNA-1 (EBER-1) and several tumor-related genes were associated with NPC carcinogenesis. Immunohistochemistry and in situ hybridization were performed on tissue microarrays containing 148 NPCs and 164 noncancerous nasopharyngeal epithelia (NPE) with different morphologic features. We found that overexpressions of EBER-1 hybridization signals, p53, p21ras, and bcl-2 proteins and loss expressions of p16 and p27 proteins were significantly increased in NPC tissues compared with normal NPE and hyperplastic NPE (P </= .001). The overexpressions of EBER-1 and p53 (P < .001) and the loss expressions of P16 (P < .001) and P27 (P = .005) were also significantly higher and more frequently observed in NPC than in dysplastic NPE. The positive expression of EBER-1 hybridization signals in NPC had significant associations with overexpressions of p53 (P < .001), p21ras (P = .041), and bcl-2 proteins (P < .001) and loss expression of p16 protein (P = .001). Further analysis confirmed that the abnormal expression of p53, p16, and p27 proteins occurred in the earliest stage of nasopharyngeal epithelial carcinogenesis. In the final logistic regression analysis model, the positive hybridization signals of EBER-1 and the abnormal expression of p53, p16, and p27 proteins were independent contributions for nasopharyngeal carcinogenesis, and EBER-1 was the most significant, independent predictor of nasopharyngeal carcinogenesis (hazard ratio = 13.412, 95% confidence interval 6.179-29.111, P < .001). In conclusion, EBV infection, together with overexpressions of p53, and loss expressions of p16 and p27 proteins are involved in the multistep process of human nasopharyngeal epithelial carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647958     DOI: 10.1016/j.humpath.2006.01.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  37 in total

1.  Identification of candidate molecular markers of nasopharyngeal carcinoma by tissue microarray and in situ hybridization.

Authors:  Shilong Xiong; Qian Wang; Lei Zheng; Feng Gao; Junling Li
Journal:  Med Oncol       Date:  2010-11-05       Impact factor: 3.064

Review 2.  Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

Authors:  James S Lewis; David J Adelstein; Abbas Agaimy; Diane L Carlson; William C Faquin; Tim Helliwell; Jos Hille; Tony Ng; John M Nicholls; Brian O'Sullivan; Lester D R Thompson
Journal:  Arch Pathol Lab Med       Date:  2018-11-30       Impact factor: 5.534

Review 3.  Tissue microarrays in clinical oncology.

Authors:  David Voduc; Challayne Kenney; Torsten O Nielsen
Journal:  Semin Radiat Oncol       Date:  2008-04       Impact factor: 5.934

4.  Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.

Authors:  Yanhong Zhou; Wei Wang; Danwei Zheng; Shuping Peng; Wei Xiong; Jian Ma; Zhaoyang Zeng; Minghua Wu; Ming Zhou; Juanjuan Xiang; Bo Xiang; Xiaoling Li; Xiayu Li; Guiyuan Li
Journal:  Med Oncol       Date:  2011-10-20       Impact factor: 3.064

Review 5.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

6.  Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.

Authors:  Wenling Zhang; Zhaoyang Zeng; Songqing Fan; Jieru Wang; Jianbo Yang; Yanhong Zhou; Xiayu Li; Donghai Huang; Fang Liang; Minghua Wu; Ke Tang; Li Cao; Xiaoling Li; Wei Xiong; Guiyuan Li
Journal:  J Mol Histol       Date:  2012-03-06       Impact factor: 2.611

7.  Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Wenling Zhang; Chen Huang; Zhaojian Gong; Yanhua Zhao; Ke Tang; Xiaoling Li; Songqing Fan; Lei Shi; Xiayu Li; Pan Zhang; Yanhong Zhou; Donghai Huang; Fang Liang; Xinli Zhang; Minghua Wu; Li Cao; Jieru Wang; Yong Li; Wei Xiong; Zhaoyang Zeng; Guiyuan Li
Journal:  J Mol Histol       Date:  2013-03-26       Impact factor: 2.611

8.  Identification of a new seven-span transmembrane protein: NGX6a is downregulated in nasopharyngeal carcinoma and is associated with tumor metastasis.

Authors:  Li Wang; Bo Xiang; Mei Yi; Wen-Ling Zhang; Jian-Bo Yang; Shu-Ping Peng; Xiao-Ling Li; Gui-Yuan Li
Journal:  J Histochem Cytochem       Date:  2009-09-15       Impact factor: 2.479

9.  Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma.

Authors:  Z Zeng; S Fan; X Zhang; S Li; M Zhou; W Xiong; M Tan; W Zhang; G Li
Journal:  Clin Transl Oncol       Date:  2015-08-11       Impact factor: 3.405

10.  Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma.

Authors:  Wenling Zhang; Songqing Fan; Guoying Zou; Lei Shi; Zhaoyang Zeng; Jian Ma; Yanhong Zhou; Xiayu Li; Xinlin Zhang; Xiaoling Li; Ming Tan; Wei Xiong; Guiyuan Li
Journal:  Tumour Biol       Date:  2014-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.